Distinct phenotypes of multisystem inflammatory syndrome in children: a cohort study

Simple item page
dc.contributor.authorRenson, Thomas
dc.contributor.authorForkert, Nils D.
dc.contributor.authorAmador, Kimberly
dc.contributor.authorMiettunen, Paivi
dc.contributor.authorParsons, Simon J.
dc.contributor.authorDhalla, Muhammed
dc.contributor.authorJohnson, Nicole A.
dc.contributor.authorLuca, Nadia
dc.contributor.authorSchmeling, Heinrike
dc.contributor.authorStevenson, Rebeka
dc.contributor.authorTwilt, Marinka
dc.contributor.authorHamiwka, Lorraine
dc.contributor.authorBenseler, Susanne
dc.date.accessioned2023-04-16T00:03:20Z
dc.date.available2023-04-16T00:03:20Z
dc.date.issued2023-04-12
dc.date.updated2023-04-16T00:03:20Z
dc.description.abstractAbstract Background Multisystem inflammatory syndrome in children (MIS-C) is a severe disease with an unpredictable course and a substantial risk of cardiogenic shock. Our objectives were to (a) compare MIS-C phenotypes across the COVID-19 pandemic, (b) identify features associated with intensive care need and treatment with biologic agents. Methods Youth aged 0–18 years, fulfilling the World Health Organization case definition of MIS-C, and admitted to the Alberta Children’s Hospital during the first four waves of the COVID-19 pandemic (May 2020-December 2021) were included in this cohort study. Demographic, clinical, biochemical, imaging, and treatment data were captured. Results Fifty-seven MIS-C patients (median age 6 years, range 0–17) were included. Thirty patients (53%) required intensive care. Patients in the third or fourth wave (indicated as phase 2 of the pandemic) presented with higher peak ferritin (µg/l, median (IQR) = 1134 (409–1806) vs. 370 (249–629), P = 0.001), NT-proBNP (ng/l, median (IQR) = 12,217 (3013–27,161) vs. 3213 (1216–8483), P = 0.02) and D-dimer (mg/l, median (IQR) = 4.81 (2.24–5.37) vs. 2.01 (1.27–3.34), P = 0.004) levels, and higher prevalence of liver enzyme abnormalities (n(%) = 17 (68) vs. 11 (34), P = 0.02), hypoalbuminemia (n(%) = 24 (100) vs. 25 (81), P = 0.03) and thrombocytopenia (n(%) 18 (72) vs. 11 (34), P = 0.007) compared to patients in the first two waves (phase 1). These patients had a higher need of non-invasive/mechanical ventilation (n(%) 4 (16) vs. 0 (0), P = 0.03). Unsupervised clustering analyses classified 47% of the patients in the correct wave and 74% in the correct phase of the pandemic. NT-proBNP was the only significant contributor to the need for intensive care in all applied multivariate regression models. Treatment with biologic agents was significantly associated with peak CRP (mg/l (median, IQR = 240.9 (132.9-319.4) vs. 155.8 (101.0-200.7), P = 0.02) and ferritin levels (µg/l, median (IQR) = 1380 (509–1753) vs. 473 (280–296)). Conclusions MIS-C patients in a later stage of the pandemic displayed a more severe phenotype, reflecting the impact of distinct SARS-CoV-2 variants. NT-proBNP emerged as the most crucial feature associated with intensive care need, underscoring the importance of monitoring.
dc.identifier.citationPediatric Rheumatology. 2023 Apr 12;21(1):33
dc.identifier.urihttps://doi.org/10.1186/s12969-023-00815-w
dc.identifier.urihttps://prism.ucalgary.ca/handle/1880/116075
dc.identifier.urihttps://dx.doi.org/10.11575/PRISM/dspace/40921
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titleDistinct phenotypes of multisystem inflammatory syndrome in children: a cohort study
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
12969_2023_Article_815.pdf
Size:
1.45 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.25 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Publications